Company intelligence / Profile preview

Liver Institute Northwest

Seattle, Washington, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Conducts Phase 2 and Phase 3 clinical trial research as a leading independent site focused on liver diseases including MASH, PBC, PSC, and hepatitis B; ongoing participation in both NIH-sponsored and industry-sponsored studies, including studies of vitamin E, novel small molecules, and biologic agents for advanced and early-stage liver disease[9][7][5].

Therapeutic areas: GastroenterologyInfectious DiseasesMetabolic Disorders
Modalities: Small moleculeBiologicDevice
Industry: Contract Research Organization

Partnerships

Velocity Clinical Research[7]National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH)[9]

Beyond the preview

Go deeper on Liver Institute Northwest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liver Institute Northwest.

Explore the full profile